Congress wants a single ALS patient to get a therapy never tested in humans. A family in Iowa believes the Food and Drug Administration will decide whether their only surviving daughter lives or dies, and they’ve been on a monthslong crusade to break through its bureaucracy. And they’re succeeding

Quick Read

Cancer drugs that speed onto the market based on encouraging preliminary studies often don’t show clear benefits when more careful follow-up trials are done, according to research published Tuesday

Quick Read

Some biotech companies are offering a new way to soften the shock of drug prices: Insurers pay only if the patient improves

Quick Read

But that can hurt you. Few people are familiar with the term “step therapy,” but most Americans have health insurance policies that adopt it. Step therapy programs, also known as “fail first policies,” require patients to try less expensive treatments before insurers agree to pay for more costly alternatives

Quick Read

Outbreaks of once-controlled diseases such as measles are rising around the world. A look at the misinformation behind the growing anti-vax movement

Quick Read

New research is zeroing in on a biochemical basis for the placebo effect — possibly opening a Pandora’s box for Western medicine

Quick Read

The manufacture and distribution of medicines is a global industry, tainted by fake and substandard products. Not only might these drugs not work as expected, but some are even contributing to antimicrobial resistance. So, what’s in your medicine cabinet?

Quick Read

Five years ago, the phrase “right to try” wasn’t yet an inkling in the minds of its staunchest advocates. Today, the pithy shorthand for the campaign to get dying patients access to experimental treatments has been slapped on bumper stickers, emblazoned on T-shirts, and uttered by some of the most powerful figures in Washington

Quick Read